https://www.live-feeds.com/feed/hims-hers-inks-deal-with-eli-lilly-to-offer-branded-weight-loss-drugsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/hims-hers-inks-deal-with-eli-lilly-to-offer-branded-weight-loss-drugshttps://www.live-feeds.com/feed/hims-hers-inks-deal-with-eli-lilly-to-offer-branded-weight-loss-drugs#u194580Wed, 11 Nov 2026 17:47:36 +0000Hims & Hers has signed a partnership agreement with pharmaceutical giant Eli Lilly to offer branded weight loss drugs directly through its platform. The collaboration aims to expand patient access to approved obesity treatments across the United States. While the deal expands product availability, the announcement arrives alongside financial pressures for the telehealth provider. Hims & Hers recently reported a share price surge following the news, though the company also faced an earlier investor selloff linked to shrinking margins, a subscriber slip, and a reduced profit outlook.Why